Frequently asked questions
  • What is Quviviq?

    Quviviq contains the active ingredient daridorexant and is used to treat chronic insomnia in adults.

  • Who is Quviviq suitable for?

    It is suitable for adults whose insomnia symptoms have lasted for at least 3 months and are having a meaningful impact on daytime functioning. It is used in adults with symptoms on 3 or more nights per week.

  • What symptoms of insomnia can it help with?

    • Trouble falling asleep
    • Difficulty staying asleep
    • Waking too early
    • Non-restorative or poor-quality sleep
  • Can Quviviq help with daytime symptoms too?

    Yes. Quviviq may help improve daytime functioning as well as nighttime sleep outcomes.

  • Do I need to have tried anything else first?

    It is recommended for adults with chronic insomnia only if CBT-I has been tried but not worked, or is unavailable or unsuitable.

  • How do I take Quviviq?

    The recommended adult dose in the attached material is one tablet once a night, every night, taken within 30 minutes before going to bed.

  • Should I take it every night?

    Yes. 

  • What if I forget to take it?

    If you forget to take Quviviq at bedtime, do not take that dose later during the night.

  • Can I take it with food?

    Yes. It can be taken with or without food, but it may take longer to work if taken with, or soon after, a large meal.

  • Can I drink alcohol while taking Quviviq?

    No. Patients should be advised to avoid drinking alcohol with Quviviq.

  • Can I drive after taking Quviviq?

    You should avoid driving or operating heavy machinery unless you feel fully alert, especially in the first few days of treatment.

  • Should I avoid grapefruit?

    Yes. You should avoid consuming grapefruit or grapefruit juice while taking Quviviq (daridorexant) because it can significantly increase the concentration of the drug in your blood, leading to a higher risk of serious side effects.

  • Who should not take Quviviq?

    • Narcolepsy
    • Hypersensitivity to daridorexant or its ingredients
    • Concomitant use of strong CYP3A4 inhibitors such as itraconazole, clarithromycin, or ritonavir.
  • Is Quviviq suitable in liver problems?

    Patients with moderate hepatic impairment may need 25 mg, and it is not recommended in severe hepatic impairment.

  • Can it be used in pregnancy?

    There are no data in pregnant women, and it should only be used if the clinical condition requires treatment.

  • Do I still need good sleep habits?

    Yes. Patients are advised to continue to practise good sleep habits while taking Quviviq.

  • Is Quviviq addictive?

    Quviviq (daridorexant) is not considered addictive when taken as prescribed, and clinical studies showed no evidence of physical dependence or withdrawal symptoms, even after long-term use.

Sign up to our newsletter

Sign up to be the first to know about promotions and news.